ACA: Uncertainty Remains After Healthcare Bill Failure But Stocks Get a Second Wind

Biotech and healthcare stocks resumed their rally today after attempts to roll back access to patients through Medicaid cuts failed yet again. An ACA repeal looks unlikely because as many as 32 million people would lose health insurance by 2026.